Abbott Indiaの収益Y / Y
Abbott Indiaの収益Y / Yは何ですか。
Abbott India Limitedの収益Y / Yは11.50%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
NSEのセクタHealth Careにおける収益Y / Yの企業と比べるAbbott India
Abbott Indiaは何をしますか。
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Abbott Indiaと類似の収益y / y
- Cipher Pharmaceuticalsの収益Y / Yは11.47%です。
- Sekisui Houseの収益Y / Yは11.47%です。
- Asian Granito Indiaの収益Y / Yは11.49%です。
- Transport of Indiaの収益Y / Yは11.49%です。
- Sanken Electric Coの収益Y / Yは11.50%です。
- ACI Worldwide Incの収益Y / Yは11.50%です。
- Abbott Indiaの収益Y / Yは11.50%です。
- Pittards plcの収益Y / Yは11.50%です。
- Corvelの収益Y / Yは11.50%です。
- Man Shun ()の収益Y / Yは11.51%です。
- MECOM Power and Constructionの収益Y / Yは11.51%です。
- International Stem Cellの収益Y / Yは11.51%です。
- Nexus AGの収益Y / Yは11.52%です。